Glaucoma: An extension of various chronic neurodegenerative disorders

Molecular Neurobiology

Volumn 48, Issue 1, 2013, Pages 186-189

  Jindal, Vishal ^a,b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b HNo 102 GHS 51 ^*  (India)

Author keywords

Alzheimer's disease; Ganglion cells; Glaucoma; Parkinsonism

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCINEURIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NFAT;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN CORTEX; CELL LOSS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GLAUCOMA; HIPPOCAMPUS; HUMAN; INTRAOCULAR HYPERTENSION; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; NONHUMAN; OPEN ANGLE GLAUCOMA; PARKINSONISM; PATHOPHYSIOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; RETINA MACULA HOLE; REVIEW; SHORT TERM MEMORY; VISUAL FIELD DEFECT; VITREOUS BODY;

EID: 84880920451     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8416-8     Document Type: Review

References (45)

1. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262-267
2. Mozaffarieh M, Grieshaber MC, Flammer J (2008) Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis 14:224-233
3. Tomita G (2000) The optic nerve head in normal-tension glaucoma. Curr Opin Ophthalmol 11:116-120
4. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, Merges CA, Pease ME, Kerrigan DF, Ransom NL, Tahzib NG, Reitsamer HA, Levkovitch-Verbin H, Quigley HA, Zack DJ (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077-1087
5. Collaborative Normal-Tension Glaucoma Study Group (1998) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126:498-505
6. Bayer AU, Ferrari F, Erb C (2002) High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 47:165-168
7. Bayer AU, Keller ON, Ferrari F, Maag KP (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 133:135-137
8. 1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289:2094-2103
9. 1-42 and tau in patients with retinal diseases. Jpn J Ophthalmol 49:106-108
10. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF (2007) Targeting amyloid-β in glaucoma treatment. Proc Natl Acad Sci USA 104:13444-13449
11. Goldblum D, Kipfer-Kauer A, Sarra GM, Wolf S, Frueh BE (2007) Distribution of amyloid precursor protein and amyloid-β immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci 48:5085-5090
12. Shimazawa M, Inokuchi Y, Okuno T, Nakajima Y, Sakaguchi G, Kato A, Oku H, Sugiyama T, Kudo T, Ikeda T, Takeda M, Hara H (2008) Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J Neurochem 107:279-290
13. Tamura H, Kawakami H, Kanamoto T et al (2006) High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 246:79-83
14. Bayer AU, Ferrari F (2002) Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye 16:209-212
15. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA et al (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 43:1077-1087
16. Kipfer-Kauer A, McKinnon SJ, Frueh BE, Goldblum D (2010) Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes. Curr Eye Res 35:828-834
17. Gupta N, Fong J, Ang LC, Yucel YH (2008) Retinal tau pathology in human glaucomas. Can J Ophthalmol 43:53-60
18. Corr̂ea S, Eales K (2012) The Role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J Signal Transduct. doi: 10.1155/2012/649079
19. Yang Y, Liu X, Huang J, Zhong Y, Mao Z, Xiao H, Mei Li M, Zhuo Y (2012) Inhibition of p38 mitogen-activated protein kinase phosphorylation decrease tert-butyl hydroperoxide-induced apoptosis in human trabecular meshwork cells. Mol Vis 18:2127-2136
20. Abdul H, Sama M, Furman J, Mathis D, Beckett T, Weidner A, Patel E, Baig I, Paul Murphy M, LeVine H, Kraner S, Norris C (2009) Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 41:12957-12969
21. Qu J, Matsouaka R, Betensky R, Hyman B, Grosskreutznz C (2012) Calcineurin activation causes retinal ganglion cell degeneration. Mol Vis 18:2828-2838
22. Cojocaru IM, Cojocaru M, Miu G, Sapira V (2011) Study of interleukin-6 production in Alzheimer's disease V. Rom J Intern Med 49:55-58
23. Sims S, Holmgren L, Cathcart H, Sappington R (2012) Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina. Am J Neurodegener Dis 1:168-179
24. Gupta N, Yucel YH (2003) Brain changes in glaucoma. Eur J Ophthalmol 13(suppl 3):S32-S35
25. Chrysostomou V, Rezania F, Trounce A, Crowston G (2013) Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol 13:12-15
26. Tezel G (2006) Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 25:490-513
27. Holasek S, Wengenack M, Kandimalla K, Montano C, Gregor M, Curran L, Poduslo F (2005) Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res 1045:185-198
28. Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson's disease. Neurotoxicology 23:487-502
29. Schapira AH (1994) Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Mov Disord 9:125-138
30. McGeer PL, Yasojima K, McGeer EG (2001) Inflammation in Parkinson's disease. Adv Neurol 86:83-89
31. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634-1658
32. Tanner CM, Goldman SM (1996) Epidemiology of Parkinson's disease. Neurol Clin 14:317-335
33. Julien C, Berthiaume L, Hadj-Tahar A, Rajput AH, Bedard PJ, Di Paolo T, Julien P, Calon F (2006) Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int 48:404-414
34. Salem N Jr (1989) Omega-3 fatty acids: molecular and biochemical aspects. In: Spiller GA, Scala J (eds) New protective roles for selected nutrients. Liss, New York, pp 109-228
35. Liss AR, New York Salem N Jr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945-959
36. Breckenridge WC, Morgan IG, Zanetta JP, Vincendon G (1973) Adult rat brain synaptic vesicles. II. Lipid composition. Biochim Biophys Acta 320:681-686
37. Akbar M, Kim HY (2002) Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochem 82:655-665
38. Akbar M, Calderon F, Wen Z, Kim HY (2005) Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A 102:10858-10863
39. Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM (2005) Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 22:617-626
40. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43:633-645
41. Jump DB (2002) Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 13:155-164
42. Bousquet M, Saint-Pierre M, Julien C, Salem N, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J 22:1213-1225
43. Boiko T, Winckler B (2006) Myelin under construction: teamwork required. J Cell Biol 172:799-801
44. Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386-399
45. Wojda I (2012) MAP kinase pathways - their evolution and role in some neurodegenerative diseases. Postepy Biochem 58:79-90